News
-
-
PRESS RELEASE
Further growth in the fourth quarter leads to annual sales of EUR 12.5 million (+2%); Important milestone achieved in antibacterial implants
aap Implantate AG reports 2% sales growth, reaching EUR 12.5 million in annual sales; Achieves milestone in antibacterial implants development, with successful human trials -
-
-
-
-
-
-
-
PRESS RELEASE
aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
CEO Rubino Di Girolamo extends contract at aap Implantate AG until 2028; COO Agnieszka Mierzejewska to leave in 2025. Company focuses on new antibacterial technology and strategic realignment